Product fact sheet
MitoPRO 1000+: Technical Specifications & Pending LightLab Test
Source-backed MitoPRO 1000+ hardware facts, including current dimensions, LED count, electrical consumption, and its still-in-progress LightLab test status.
A mid-size four-wavelength MitoPRO+ panel with current manufacturer specifications; Mito's independent-test index says its LightLab test is still in progress and replaces the former 750+ slot.
mid-size MitoPRO+ specification comparisons, buyers who want the current replacement model documented without pretending pending lab work is complete
comparisons requiring completed accredited radiometric data, anyone substituting the manufacturer's irradiance claim for the pending LightLab measurement
Key tradeoff: The current physical and electrical specifications are clear, while the independent radiometric record remains explicitly incomplete.
This is a factual fit-and-tradeoff summary, not a product recommendation. Formula, device and brand claims remain manufacturer claims unless the cited source is explicitly regulatory or independent testing.
The MitoPRO 1000+ is the current mid-size model in Mito Red Light’s four-wavelength MitoPRO+ family. Its manufacturer page documents the physical and electrical specifications, while the current independent-test index says the model’s LightLab test is still in progress.
The independent test is not complete yet
Mito’s independent-test index lists the MitoPRO 1000+ as “Test in progress · April 2026 · Replaces 750+.” Homeapotherapy therefore does not populate independent wall draw, total radiant power, average irradiance, or peak irradiance fields for this product yet.
That distinction matters because the manufacturer page already publishes irradiance figures. Those figures remain manufacturer-published measurements and are not relabeled as completed accredited-lab data while the dedicated LightLab record is still pending.
Current manufacturer-documented hardware
The current comparison table lists a 12 × 24 inch panel-only footprint, 17 lb weight, 200 LEDs, and 270 W published power consumption. Published peak wavelengths are 630, 660, 830, and 850 nm.
What remains unknown
Until Mito publishes the completed test, the normalized record has no third-party wall draw, radiant power, spatial-average irradiance, or peak irradiance for the 1000+. Homeapotherapy has not hands-on tested the device.
For help interpreting those fields, see How to Read Red Light Device Specifications.
Technical specifications
Published specs and what they mean
Physical
- Panel dimensions
- 12 × 24 in (W × H; panel only) Basis: Manufacturer published Current manufacturer comparison table. Source: MitoPRO+ Red Light Therapy Panels
- Weight
- 17 lb Basis: Manufacturer published Current manufacturer comparison table. Source: MitoPRO+ Red Light Therapy Panels
Optical
- Published wavelengths
- 630 / 660 / 830 / 850 nm Basis: Manufacturer published Current manufacturer comparison table. Source: MitoPRO+ Red Light Therapy Panels
- LED count
- 200 LEDs Basis: Manufacturer published Current manufacturer comparison table. Source: MitoPRO+ Red Light Therapy Panels
Electrical
- Published power consumption
- 270 W Basis: Manufacturer published Current manufacturer comparison table; not an independent wall-draw measurement. Source: MitoPRO+ Red Light Therapy Panels
What the current record does not establish
- Mito's independent-test index states: Test in progress · April 2026 · Replaces 750+.
- No normalized independent wall draw, radiant power, average irradiance or peak irradiance is recorded until the LightLab result is published.
- Homeapotherapy has not independently tested the device.
A missing field is not evidence that the device lacks the feature or performs poorly. It means we do not currently have a sufficiently comparable, sourced value in the normalized record.
Source labels preserve provenance. Manufacturer specifications, ingredient lists and performance claims are not treated as independent clinical evidence; regulatory records and independent measurements are identified separately when available.
Dose and irradiance context
What the output number means over time
Fluence is a calculation, not a treatment recommendation. For continuous output, fluence in J/cm² equals irradiance in mW/cm² × seconds ÷ 1000. The calculation only remains meaningful at the measurement conditions used for the irradiance value.
No comparable independent average irradiance is normalized
This device may have a manufacturer-published irradiance claim, but Homeapotherapy does not calculate time-to-fluence from that number unless the current record contains a sufficiently defined independent area-average measurement. This avoids presenting unlike measurement methods as interchangeable.
What this calculation still cannot tell you
- whether this is an effective dose for any condition;
- how irradiance changes at a different distance or across curved anatomy;
- how much energy reaches tissue below the surface;
- whether a study used the same wavelength distribution, spot size, pulse mode or treatment schedule;
- whether peak irradiance would produce the same area exposure as the average value shown here.
Read Red Light Irradiance, Fluence and Dose Explained before trying to compare this output with a clinical paper or another panel.
Clinical evidence context
Where these wavelengths overlap with human research
Published device wavelengths: 630 / 660 / 830 / 850 nm.
This is a hardware-to-literature cross-reference, not a claim that this product treats any condition. A matching nominal wavelength does not reproduce a study's irradiance, dose, distance, treatment area, emitter geometry, schedule or patient population.
Research areas worth checking
- Pattern hair loss — human studies commonly use visible-red wavelengths, especially around the mid-600 nm range.
- Acne and inflammatory skin — red-light protocols exist, but acne studies may also use blue light and should not be generalized from panel specs.
- Skin rejuvenation and photoaging — visible-red and red/NIR LED protocols have been studied with varied devices and endpoints.
- Knee osteoarthritis — near-infrared wavelengths appear in the clinical literature, but wavelength alone does not establish an equivalent treatment protocol.
- Muscle recovery and musculoskeletal pain — research spans red and near-infrared bands with substantial protocol variation.
- Transcranial PBM and cognition — some research uses near-infrared wavelengths, but a body panel is not automatically equivalent to a head-targeted transcranial device.
- See the full wavelength-by-condition evidence chart for evidence strength, treatment geometry and major caveats.
Do not infer from wavelength overlap
- that this device is clinically proven for the linked condition;
- that more wavelengths are better;
- that the highest published irradiance is the best dose;
- that an open wound should be treated with a consumer device without appropriate wound assessment.
For wounds specifically, start with the wound-care safety decision guide before interpreting any device specification.
Safety first
What should make you slow down?
Use the product as directed, avoid treating concentrated wellness products as automatically harmless, and ask a qualified clinician when your situation or medication use makes the decision less routine.
Where to buy
Current tracked merchants
Commerce note: merchant economics never enter our editorial score. Affiliate links are identified as (paid link) and use sponsored-link markup.
No merchant destination is currently tracked for this product.
Source trail
Primary documents and supporting evidence
- MitoPRO+ Red Light Therapy PanelsMito Red Light · Manufacturer · retrieved 2026-08-11
- Independent ISO/IEC 17025 Panel Test DataMito Red Light / LightLab International · Independent lab · HTML data index · retrieved 2026-08-11
- Product Manuals & VideosMito Red Light · Manufacturer manual · Manual index · retrieved 2026-08-11